Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

8 results
Display

Anti-Ri-Antibody-Associated Paraneoplastic Syndrome in a Man with Breast Cancer Showing a Reversible Pontine Lesion on MRI

Kim H, Lim Y, Kim KK

  • J Clin Neurol.
  • 2009 Sep;5(3):151-152.
  • doi: 10.3988/jcn.2009.5.3.151
BACKGROUND: Paraneoplastic neurological disorders associated with anti-Ri-antibodies, which are typically present with opsoclonus-myoclonus-ataxia. Most cases with anti-Ri-antibodyassociated paraneoplastic syndrome due to breast cancer occur in women - its occurrence in...
Common Carotid Artery Agenesis: Duplex Ultrasonographic Findings

Yim SJ, Ryu JH, Baik JS, Kim JY, Park JH, Han SW

  • J Clin Neurol.
  • 2009 Sep;5(3):149-150.
  • doi: 10.3988/jcn.2009.5.3.149
BACKGROUND: Agenesis of the common carotid artery (CCA) resulting in separation of the origin of the external carotid artery (ECA) and internal carotid artery (ICA) from the aortic arch is...
Secondary Amyloidosis Associated with Multiple Sclerosis

Kang SJ, Yi JH, Hong HS, Jang SH, Park MH, Kim HJ, Lee KY, Lee YJ, Han SW, Koh SH

  • J Clin Neurol.
  • 2009 Sep;5(3):146-148.
  • doi: 10.3988/jcn.2009.5.3.146
BACKGROUND: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system. Secondary amyloidosis can occur as a complication of chronic systemic inflammatory and infectious diseases. Until now there...
Relationships between 24-Hour Blood Pressures, Subcortical Ischemic Lesions, and Cognitive Impairment

Kim JE, Shin JS, Jeong JH, Choi KG, Park KD, Kim S

  • J Clin Neurol.
  • 2009 Sep;5(3):139-145.
  • doi: 10.3988/jcn.2009.5.3.139
BACKGROUND AND PURPOSE: The most important treatment for subcortical vascular dementia (SVaD) is controlling the blood pressure (BP). However, the few studies that have investigated the relationships between diurnal BP...
Cognitive Impairment in Parkinson's Disease without Dementia: Subtypes and Influences of Age

Kim JW, Cheon SM, Park MJ, Kim S, Jo HY

  • J Clin Neurol.
  • 2009 Sep;5(3):133-138.
  • doi: 10.3988/jcn.2009.5.3.133
BACKGROUND AND PURPOSE: Cognitive impairments are common in Parkinson's disease (PD), although the severity of these impairments does not significantly impair the patient's daily activities. The aim of this study...
Levels of Soluble Receptor for Advanced Glycation End Products in Acute Ischemic Stroke without a Source of Cardioembolism

Park HY, Yun KH, Park DS

  • J Clin Neurol.
  • 2009 Sep;5(3):126-132.
  • doi: 10.3988/jcn.2009.5.3.126
BACKGROUND AND PURPOSE: Low levels of soluble receptor for advanced glycation end products (sRAGE) are associated with three conventional vascular risk factors (3Fs: diabetes, hypertension, and hypercholesterolemia), nondiabetic coronary artery...
Potential Role of Sirtuin as a Therapeutic Target for Neurodegenerative Diseases

Han SH

  • J Clin Neurol.
  • 2009 Sep;5(3):120-125.
  • doi: 10.3988/jcn.2009.5.3.120
The sirtuins (SIRTs) are protein-modifying enzymes that are distributed ubiquitously in all organisms. SIRT1 is a mammalian homologue of yeast nicotinamide-adenine-dinucleotide-dependent deacetylase silent information regulator 2 (known as Sir2), which...
Multimodal MRI for Ischemic Stroke: From Acute Therapy to Preventive Strategies

Bang OY

  • J Clin Neurol.
  • 2009 Sep;5(3):107-119.
  • doi: 10.3988/jcn.2009.5.3.107
BACKGROUND AND PURPOSE: Conventional therapies for ischemic stroke include thrombolytic therapy, prevention of inappropriate coagulation and thrombosis, and surgery to repair vascular abnormalities. Over 10 years have passed since the...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr